Press Release: Oxford BioTherapeutics : Oxford BioTherapeutics to Present at 35th Cowen and Company Annual Health Care Conference in Boston

OXFORD, England and SAN JOSE, California, February 23, 2015 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, announces that it will present at the 35th...